GSK256066 is an exceptionally high affinity and selective inhibitor of PDE4 that inhibits PDE4 isoforms A-D with equal affinity and has a high HARBS (High-Affinity Rolipram Binding Site) ratio (>17).
More Information Supplier PageGSK256066 is an exceptionally high affinity and selective inhibitor of PDE4 that inhibits PDE4 isoforms A-D with equal affinity and has a high HARBS (High-Affinity Rolipram Binding Site) ratio (>17).
More Information Supplier PageADL5859 HCl is a highly potent and selective ?? opioid receptor agonist with Ki value to be 0.84 nM and ED50 value to be 20 nM.
More Information Supplier PageADL5859 HCl is a highly potent and selective ?? opioid receptor agonist with Ki value to be 0.84 nM and ED50 value to be 20 nM.
More Information Supplier PageTAK-901 is a small-molecule inhibitor of the serine-threonine kinase Aurora B with potential antineoplastic activity.
More Information Supplier PageTAK-901 is a small-molecule inhibitor of the serine-threonine kinase Aurora B with potential antineoplastic activity.
More Information Supplier PageTAK-901 is a small-molecule inhibitor of the serine-threonine kinase Aurora B with potential antineoplastic activity.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier Page
